Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer
Ali H. El-Far,Kavitha Godugu,Taher A. Salaheldin,Noureldien H. E. Darwish,Amna A. Saddiq,Shaker A. Mousa
Biomedicines.2021;9(8)990
[DOI]
2Free- and liposomal- doxorubicin delivery via microbubble inertial cavitation
Martynas Maciulevicius,Mindaugas Tamošiunas,Diana Navickaite,Saulius Šatkauskas,Mindaugas S. Venslauskas
Journal of Drug Delivery Science and Technology.2022;72(8)103386
[DOI]
3Antitumor Features of Vegetal Protein-Based Nanotherapeutics
Silvia Voci,Agnese Gagliardi,Massimo Fresta,Donato Cosco
Pharmaceutics.2020;12(1)65
[DOI]
4Multi-Functional Liposome: A Powerful Theranostic Nano-Platform Enhancing Photodynamic Therapy
Xiamin Cheng,Jing Gao,Yang Ding,Yao Lu,Qiancheng Wei,Dezhi Cui,Jiali Fan,Xiaoman Li,Ershu Zhu,Yongna Lu,Qiong Wu,Lin Li,Wei Huang
Advanced Science.2021;8(16)2100876
[DOI]
5Disruption of mitochondrial function as mechanism for anti-cancer activity of a novel mitochondriotropic menadione derivative
José Teixeira,Ricardo Amorim,Katia Santos,Pedro Soares,Sandipan Datta,Gino A. Cortopassi,Teresa L. Serafim,Vilma A. Sardão,Jorge Garrido,Fernanda Borges,Paulo J. Oliveira
Toxicology.2018;393(16)123
[DOI]
6Tumor targeting antibody-conjugated nanocarrier with pH/thermo dual-responsive macromolecular film layer for enhanced cancer chemotherapy
Jiafeng Zhuang,Lina Zhou,Wen Tang,Tonghao Ma,Hui Li,Xiaoli Wang,Chao Chen,Ping Wang
Materials Science and Engineering: C.2021;118(16)111361
[DOI]
7Drug-Loaded Mucoadhesive Patch with Active Delivery and Controlled Releasing Ability
Jihun Lee,Dong-in Kim,Seungmin Bang,Sukho Park
Advanced Intelligent Systems.2022;4(4)2100203
[DOI]
8Multi-liposomal containers
A.A. Yaroslavov,A.V. Sybachin,O.V. Zaborova,A.B. Zezin,Y. Talmon,M. Ballauff,F.M. Menger
Advances in Colloid and Interface Science.2015;226(4)54
[DOI]
9Doxorubicin-loaded composite nanogels for cancer treatment
Marzieh Mohammadi,Leila Arabi,Mona Alibolandi
Journal of Controlled Release.2020;328(4)171
[DOI]
10Cerium oxide nanoparticles: In pursuit of liver protection against doxorubicin-induced injury in rats
Heba G. Ibrahim,Noha Attia,Fatma El Zahraa A. Hashem,Moushira A.R. El Heneidy
Biomedicine & Pharmacotherapy.2018;103(4)773
[DOI]
11Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
Franziska Hartung,Luis A. Pardo
European Biophysics Journal.2016;45(7)709
[DOI]
12Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
Rosie Elizabeth Ann Gutteridge,Mary Ann Ndiaye,Xiaoqi Liu,Nihal Ahmad
Molecular Cancer Therapeutics.2016;15(7)1427
[DOI]
13pH-Responsive diblock copolymers made of ?-pentadecalactone and ionically charged a-amino acids
Ernesto Tinajero-Díaz,Antxon Martínez de Ilarduya,Sebastián Muñoz-Guerra
European Polymer Journal.2019;120(7)109244
[DOI]
14Protein phosphatase 1 in tumorigenesis: is it worth a closer look?
Juliana Felgueiras,Carmen Jerónimo,Margarida Fardilha
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2020;1874(2)188433
[DOI]
15Highly stable near-infrared dye conjugated cerasomes for fluorescence imaging-guided synergistic chemo-photothermal therapy of colorectal cancer
Xu Zhang,Xiaolong Liang,Xiaotu Ma,Rui Hou,Xiaoda Li,Fan Wang
Biomaterials Science.2019;7(7)2873
[DOI]
16Glucoheptoamidated polyamidoamine PAMAM G3 dendrimer as a vehicle for succinate linked doxorubicin; enhanced toxicity of DOX against grade IV glioblastoma U-118 MG cells
Justyna Czarnik-Kwasniak,Konrad Kwasniak,Krzysztof Tutaj,Iwona Filiks,Lukasz Uram,Monika Stompor,Stanislaw Wolowiec
Journal of Drug Delivery Science and Technology.2020;55(7)101424
[DOI]
17Effective drug delivery system based on hydrophobin and halloysite clay nanotubes for sustained release of doxorubicin
Bo Wang,Zhiqiang Han,Bo Song,Long Yu,Zhongqiang Ma,Haijin Xu,Mingqiang Qiao
Colloids and Surfaces A: Physicochemical and Engineering Aspects.2021;628(7)127351
[DOI]
18Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance
Yan Chen,Yao Cheng,Pengxuan Zhao,Shasha Zhang,Minsi Li,Chuanchuan He,Xiaojuan Zhang,Tan Yang,Ruicong Yan,Peng Ye,Xiang Ma,Guangya Xiang
International Journal of Pharmaceutics.2018;542(1-2)266
[DOI]
19Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance
Jan Scicinski,Bryan Oronsky,Scott Caroen,Pedro Cabrales,Thomas A. Summers,Tony R. Reid,Michelle M. Kim,Jane B. Trepel,Min-Jung Lee,Nacer D. Abrouk,Regina M. Day,Saheli Jha,Arnold Oronsky,Corey A. Carter
International Journal of Pharmaceutics.2017;542(1-2)35
[DOI]
20The Mechanism of Dynamic Interaction between Doxorubicin and Calf Thymus DNA at the Single-Molecule Level Based on Confocal Raman Spectroscopy
Ruihong Zhang,Jie Zhu,Dan Sun,Jie Li,Lina Yao,Shuangshuang Meng,Yan Li,Yang Dang,Kaige Wang
Micromachines.2022;13(6)940
[DOI]
21Photoresponsive Micelle-Incorporated Doxorubicin for Chemo-Photodynamic Therapy to Achieve Synergistic Antitumor Effects
Da Hye Kim,Hee Sook Hwang,Kun Na
Biomacromolecules.2018;19(8)3301
[DOI]
22Assessing Advantages and Drawbacks of Rapidly Generated Ultra-Large 3D Breast Cancer Spheroids: Studies with Chemotherapeutics and Nanoparticles
Austin R. Holub,Anderson Huo,Kavil Patel,Vishal Thakore,Pranav Chhibber,Folarin Erogbogbo
International Journal of Molecular Sciences.2020;21(12)4413
[DOI]
23Engineering the early bone metastatic niche through human vascularized immuno bone minitissues
Maria Vittoria Colombo,Simone Bersini,Chiara Arrigoni,Mara Gilardi,Veronica Sansoni,Enrico Ragni,Gabriele Candiani,Giovanni Lombardi,Matteo Moretti
Biofabrication.2021;13(3)035036
[DOI]
24Anthraquinones as Inhibitors of SOS RAS-GEF Activity
Alberto Fernández-Medarde,Rocío Fuentes-Mateos,Rósula García-Navas,Andrea Olarte-San Juan,José María Sánchez-López,Antonio Fernández-Medarde,Eugenio Santos
Biomolecules.2021;11(8)1128
[DOI]
25Key Signaling Pathways Engaged in Cancer Management: Current Update
Sanjiv Singh,Rahul Shukla
Current Cancer Therapy Reviews.2020;16(1)36
[DOI]
26Reversing P-Glycoprotein-Associated Multidrug Resistance of Breast Cancer by Targeted Acid-Cleavable Polysaccharide Nanoparticles with Lapatinib Sensitization
Junhui Sui,Mengmeng He,Yuedi Yang,Mengcheng Ma,Zhihao Guo,Mingda Zhao,Jie Liang,Yong Sun,Yujiang Fan,Xingdong Zhang
ACS Applied Materials & Interfaces.2020;12(46)51198
[DOI]
27Design and Synthesis of Menthol and Thymol Derived Ciprofloxacin: Influence of Structural Modifications on the Antibacterial Activity and Anticancer Properties
Tomasz Szostek,Daniel Szulczyk,Jolanta Szymanska-Majchrzak,Michal Kolinski,Sebastian Kmiecik,Dagmara Otto-Slusarczyk,Aleksandra Zawodnik,Eliza Rajkowska,Kinga Chaniewicz,Marta Struga,Piotr Roszkowski
International Journal of Molecular Sciences.2022;23(12)6600
[DOI]
28CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
Jian Gao,Qianqian Zheng,Yue Shao,Wei Wang,Chenghai Zhao
Apoptosis.2018;23(9-10)512
[DOI]
29Chemosensitizing activity of Cuban propolis and nemorosone in doxorubicin resistant human colon carcinoma cells
Yahima Frión-Herrera,Daniela Gabbia,Alexis Díaz-García,Osmany Cuesta-Rubio,Maria Carrara
Fitoterapia.2019;136(9-10)104173
[DOI]
30Differential changes in the pharmacokinetics of doxorubicin in diethylnitrosamine-induced hepatocarcinoma model rats
Jie Pan,Yuan Lu,Shuai Zhang,Yueting Li,Jia Sun,Hua Chunhua Liu,Zipeng Gong,Jing Huang,Chuang Cao,Yonglin Wang,Yongjun Li,Ting Liu
Xenobiotica.2020;50(10)1251
[DOI]
31Catalpol alleviates adriamycin-induced nephropathy by activating the SIRT1 signalling pathway in vivo and in vitro
Jiangnan Zhang,Ran Bi,Qiang Meng,Changyuan Wang,Xiaokui Huo,Zhihao Liu,Chong Wang,Pengyuan Sun,Huijun Sun,Xiaodong Ma,Jingjing Wu,Kexin Liu
British Journal of Pharmacology.2019;176(23)4558
[DOI]
32Effective delivery of hydrophobic drugs to breast and liver cancer cells using a hybrid inorganic nanocarrier: A detailed investigation using cytotoxicity assays, fluorescence imaging and flow cytometry
Danushika C. Manatunga,Rohini M. de Silva,K.M. Nalin de Silva,Gathsaurie Neelika Malavige,Dulharie T. Wijeratne,Gareth R. Williams,Chanika D. Jayasinghe,Preethi V. Udagama
European Journal of Pharmaceutics and Biopharmaceutics.2018;128(23)18
[DOI]
33Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
Ying Liu,Xiang Ao,Yu Wang,Xiaoge Li,Jianxun Wang
Frontiers in Oncology.2022;12(23)18
[DOI]
34The efficacy and safety of pegylated liposomal doxorubicin monotherapy and combination therapy with carboplatin in Korean patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer: a single-institution experience
Young-Jae Lee,Yong-Man Kim,Shin-Wha Lee,Jeong-Yeol Park,Dae-Yeon Kim,Dae-Shik Suh,Jong-Hyeok Kim,Young-Tak Kim,Joo-Hyun Nam
Obstetrics & Gynecology Science.2017;60(5)433
[DOI]
35ß-Elemene Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin via Downregulation of Peroxiredoxin-1
Shaochun Zhang,Weichun Guo
OncoTargets and Therapy.2021;Volume 14(5)3599
[DOI]
36Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma
Mojgan Nejabat,Marzieh Mohammadi,Khalil Abnous,Seyed Mohammad Taghdisi,Mohammad Ramezani,Mona Alibolandi
Carbohydrate Polymers.2018;197(5)157
[DOI]
37Cellulose acetate encapsulated upconversion nanoparticles – A novel theranostic platform
Seda Demirel Topel,Sevgi Balcioglu,Burhan Ates,Meltem Asilturk,Önder Topel,Marica B. Ericson
Materials Today Communications.2021;26(5)101829
[DOI]
38Thymoquinone and Costunolide Induce Apoptosis of Both Proliferative and Doxorubicin-Induced-Senescent Colon and Breast Cancer Cells
Ali H El-Far,Kavitha Godugu,Ahmed E. Noreldin,Amna A. Saddiq,Omar A. Almaghrabi,Soad K. Al Jaouni,Shaker A. Mousa
Integrative Cancer Therapies.2021;20(5)153473542110354
[DOI]
39Folic acid-appended galactoxyloglucan-capped iron oxide nanoparticles as a biocompatible nanotheranostic agent for tumor-targeted delivery of doxorubicin
B.S. Unnikrishnan,Anitha Sen,G.U. Preethi,Manu M. Joseph,S. Maya,R. Shiji,K.S. Anusree,T.T. Sreelekha
International Journal of Biological Macromolecules.2021;168(5)130
[DOI]
40Crosstalk between E2F1 and P53 transcription factors in doxorubicin-induced DNA damage: evidence for preventive/protective effects of silymarin
Seyedeh-Khadijeh Shafiei-Roudbari,Hassan Malekinejad,Hamed Janbaz-Aciabar,Mazdak Razi
Journal of Pharmacy and Pharmacology.2017;69(9)1116
[DOI]
41Morin Inhibits Dox-Induced Vascular Inflammation By Regulating PTEN/AKT/NF-?B Pathway
Jing Yu,Hai-Liang Qi,Hong Zhang,Zi-Yu Zhao,Zi-Yu Jing-Zhao,Zi-Yuan Nie
Inflammation.2022;69(9)1116
[DOI]
42Albumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer
Rama Prajapati,Eduardo Garcia-Garrido,Álvaro Somoza
Cancers.2021;13(12)3011
[DOI]
43Construction and antitumor properties of a targeted nano-drug carrier system responsive to the tumor microenvironment
Wenzhao Han,Junfeng Ke,Feng Guo,Fanwei Meng,Hui Li,Liping Wang
International Journal of Pharmaceutics.2021;608(12)121066
[DOI]
44Doxorubicin-Conjugated Iron Oxide Nanoparticles Synthesized by Laser Pyrolysis: In Vitro Study on Human Breast Cancer Cells
Iulia Ioana Lungu,Simona Nistorescu,Madalina Andreea Badea,Andreea-Mihaela Petre,Ana-Maria Udrea,Ana-Maria Banici,Claudiu Fleaca,Ecaterina Andronescu,Anca Dinischiotu,Florian Dumitrache,Angela Staicu,Mihaela Bala?
Polymers.2020;12(12)2799
[DOI]
45A quantitative systems pharmacology approach to predict the safe-equivalent dose of doxorubicin in patients with cardiovascular comorbidity
Lan Sang,Yi Yuan,Ying Zhou,Zhengying Zhou,Muhan Jiang,Xiaoquan Liu,Kun Hao,Hua He
CPT: Pharmacometrics & Systems Pharmacology.2021;10(12)1512
[DOI]
46Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology
Milad Ashrafizadeh,Shahin Aghamiri,Shing Cheng Tan,Ali Zarrabi,Esmaeel Sharifi,Navid Rabiee,Firoz Babu Kadumudi,Alireza Dolatshahi Pirouz,Masoud Delfi,Kullaiah Byrappa,Vijay Kumar Thakur,Kothanahally S. Sharath Kumar,Yarabahally R. Girish,Farshid Zandsalimi,Ehsan Nazarzadeh Zare,Gorka Orive,Franklin Tay,Kiavash Hushmandi,Alan Prem Kumar,Ceren Karaman,Hassan Karimi-Maleh,Ebrahim Mostafavi,Pooyan Makvandi,Yuzhuo Wang
Nano Today.2022;45(12)101532
[DOI]
47New doxorubicin nanoparticles engineered from calcium-crosslinked carbomer and a microemulsion precursor
Amnon C. Sintov,Giora Enden
Drug Development and Industrial Pharmacy.2017;43(5)830
[DOI]
48Dual-targeted and controlled release delivery of doxorubicin to breast adenocarcinoma: In vitro and in vivo studies
Zahra Jamshidi,Taraneh Sadat Zavvar,Mohammad Ramezani,Mona Alibolandi,Farzin Hadizadeh,Khalil Abnous,Seyed Mohammad Taghdisi
International Journal of Pharmaceutics.2022;623(5)121892
[DOI]
49Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma
Muhammad Ismail,Wen Yang,Yanfei Li,Tianran Chai,Dongya Zhang,Qiuli Du,Pir Muhammad,Sumaira Hanif,Meng Zheng,Bingyang Shi
Biomaterials.2022;287(5)121608
[DOI]
50Electrosprayed Myocet-like Liposomes: An Alternative to Traditional Liposome Production
Michael A. Collier,Eric M. Bachelder,Kristy M. Ainslie
Pharmaceutical Research.2017;34(2)419
[DOI]
51Multiplex Three-Dimensional Mapping of Macromolecular Drug Distribution in the Tumor Microenvironment
Steve Seung-Young Lee,Vytautas P. Bindokas,Stephen J. Kron
Molecular Cancer Therapeutics.2019;18(1)213
[DOI]
52Doxorubicin Loaded Poloxamer Thermosensitive Hydrogels: Chemical, Pharmacological and Biological Evaluation
Chih Kit Chung,Jomarien García-Couce,Yaima Campos,Dana Kralisch,Katja Bierau,Alan Chan,Ferry Ossendorp,Luis Javier Cruz
Molecules.2020;25(9)2219
[DOI]
53Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition
Fu-Yi Cai,Xue-Min Yao,Ming Jing,Liang Kong,Jing-Jing Liu,Min Fu,Xin-Ze Liu,Lu Zhang,Si-Yu He,Xue-Tao Li,Rui-Jun Ju
Journal of Liposome Research.2021;31(2)113
[DOI]
54Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition
Riyaz Ali M. Osmani,Parthasarathi K. Kulkarni,Vishakante Gowda,Umme Hani,Vishal K. Gupta,Madesh Prerana,Chandani Saha
Journal of Liposome Research.2018;31(2)97
[DOI]
55Reductive responsive micelle overcoming multidrug resistance of breast cancer by co-delivery of DOX and specific antibiotic
Yani Cui,Yuedi Yang,Mengcheng Ma,Yang Xu,Junhui Sui,Huifang Li,Jie Liang,Yong Sun,Yujiang Fan,Xingdong Zhang
Journal of Materials Chemistry B.2019;7(40)6075
[DOI]
56Hyperthermia Enhances Doxorubicin Therapeutic Efficacy against A375 and MNT-1 Melanoma Cells
Diana Salvador,Verónica Bastos,Helena Oliveira
International Journal of Molecular Sciences.2021;23(1)35
[DOI]
57Chemical Structures and Cell Death Inducing Activities of Constituents Isolated from Hibiscus tiliaceus
Takahiro Matsumoto,Tetsushi Watanabe,Takahiro Kitagawa,Daisuke Imahori
HETEROCYCLES.2022;104(8)1477
[DOI]
58Krebs Cycle Intermediate-Modified Carbonate Apatite Nanoparticles Drastically Reduce Mouse Tumor Burden and Toxicity by Restricting Broad Tissue Distribution of Anticancer Drugs
Sultana Mehbuba Hossain,Syafiq Asnawi Zainal Abidin,Ezharul Hoque Chowdhury
Cancers.2020;12(1)161
[DOI]
59Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance
Nirmala Tilija Pun,Chul-Ho Jeong
Pharmaceuticals.2021;14(5)470
[DOI]
60Folic acid-doxorubicin polymeric nanocapsules: A promising formulation for the treatment of triple-negative breast cancer
Rodrigo Cé,Gabriela Klein Couto,Barbara Zoche Pacheco,Danieli Rosane Dallemole,Júlia Damé Paschoal,Bruna Silveira Pacheco,Silvia Stanisçuaski Guterres,Fabiana Seixas,Tiago Collares,Adriana Raffin Pohlmann
European Journal of Pharmaceutical Sciences.2021;165(5)105943
[DOI]
61Facile Fabrication Route of Janus Gold-Mesoporous Silica Nanocarriers with Dual-Drug Delivery for Tumor Therapy
Yang Xing,Ying Zhou,Yan Zhang,Caihong Zhang,Xu Deng,Chuan Dong,Shaomin Shuang
ACS Biomaterials Science & Engineering.2020;6(3)1573
[DOI]
62Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization
Vivek Makwana,Jasmine Karanjia,Thomas Haselhorst,Shailendra Anoopkumar-Dukie,Santosh Rudrawar
International Journal of Pharmaceutics.2021;593(3)120117
[DOI]
63Topoisomerases as anticancer targets
Justine L. Delgado,Chao-Ming Hsieh,Nei-Li Chan,Hiroshi Hiasa
Biochemical Journal.2018;475(2)373
[DOI]
64Galectin-3 inhibition attenuates doxorubicin-induced cardiac dysfunction by upregulating the expression of peroxiredoxin-4
Yunpeng Tian,Wei Lv,Chengzhi Lu,Yiyao Jiang,Xue Yang,Minghao Song
Canadian Journal of Physiology and Pharmacology.2020;98(10)700
[DOI]
65Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: The role of Quercetin in modulating these processes
Elisa Bientinesi,Matteo Lulli,Matteo Becatti,Sara Ristori,Francesca Margheri,Daniela Monti
Mechanisms of Ageing and Development.2022;206(10)111689
[DOI]
66Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells
Jian-an Pan,Hui Zhang,Hao Lin,Lin Gao,Hui-li Zhang,Jun-feng Zhang,Chang-qian Wang,Jun Gu
Redox Biology.2021;46(10)102120
[DOI]
67Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies
Ana Cláudia Santos,Diana Costa,Laura Ferreira,Catarina Guerra,Miguel Pereira-Silva,Irina Pereira,Diana Peixoto,Nuno R. Ferreira,Francisco Veiga
Drug Delivery and Translational Research.2021;11(1)49
[DOI]
68Role of miRNAs in regulating responses to radiotherapy in human breast cancer
Zhi Xiong Chong,Swee Keong Yeap,Wan Yong Ho
International Journal of Radiation Biology.2021;97(3)289
[DOI]
69Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity
Ali H El-Far,Taher A Salaheldin,Kavitha Godugu,Noureldien HE Darwish,Shaker A Mousa
Nanomedicine.2021;16(17)1457
[DOI]
70Doxorubicin delivery by magnetic nanotheranostics enhances the cell death in chemoresistant colorectal cancer-derived cells
María Julia Martín,Pamela Azcona,Verónica Lassalle,Claudia Gentili
European Journal of Pharmaceutical Sciences.2021;158(17)105681
[DOI]
71Indispensable role of microbes in anticancer drugs and discovery trends
Ridam Kapoor,Anamika Saini,Deepika Sharma
Applied Microbiology and Biotechnology.2022;106(13-16)4885
[DOI]
72Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
Khine Kyaw Oo,Thanpawee Kamolhan,Anish Soni,Suyanee Thongchot,Chalermchai Mitrpant,Pornchai O-charoenrat,Chanitra Thuwajit,Peti Thuwajit
BMC Cancer.2021;21(1)4885
[DOI]
73Synthesis of a new water-soluble hexacarboxylated tribenzotriquinacene derivative and its competitive host–guest interaction for drug delivery
Man-Ping Li,Nan Yang,Wen-Rong Xu
Beilstein Journal of Organic Chemistry.2022;18(1)539
[DOI]
74Titanium Dioxide Nanoparticles: Prospects and Applications in Medicine
Daniel Ziental,Beata Czarczynska-Goslinska,Dariusz T. Mlynarczyk,Arleta Glowacka-Sobotta,Beata Stanisz,Tomasz Goslinski,Lukasz Sobotta
Nanomaterials.2020;10(2)387
[DOI]
75Angelica gigas Nakai Has Synergetic Effects on Doxorubicin-Induced Apoptosis
Yong-Joon Jeon,Jong-Il Shin,Sol Lee,Yoon Gyeong Lee,Ji Beom Kim,Hak Cheol Kwon,Sung Hun Kim,Inki Kim,Kyungho Lee,Ye Sun Han
BioMed Research International.2018;2018(2)1
[DOI]
76Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer Therapy
Zekun Pang,Jiayan Zhou,Chunyang Sun
Frontiers in Chemistry.2020;8(2)1
[DOI]
77Toxic effects and molecular mechanism of doxorubicin on different organs – an update
Kaviyarasi Renu,Lakshmi Prasanna Pureti,Balachandar Vellingiri,Abilash Valsala Gopalakrishnan
Toxin Reviews.2022;41(2)650
[DOI]
78Strategies to release doxorubicin from doxorubicin delivery vehicles
Juan Li,Bin Zhang,Chunwen Yue,Jing Wu,Lanxia Zhao,Deqing Sun,Rongmei Wang
Journal of Drug Targeting.2018;26(1)9
[DOI]
79Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines
Tânia Capelôa,Zohra Benyahia,Luca X. Zampieri,Marine C.N.M. Blackman,Pierre Sonveaux
Seminars in Cell & Developmental Biology.2020;98(1)181
[DOI]
80Liquid Chromatography–Tandem Mass Spectrometry for the Simultaneous Determination of Doxorubicin and its Metabolites Doxorubicinol, Doxorubicinone, Doxorubicinolone, and 7-Deoxydoxorubicinone in Mouse Plasma
Won-Gu Choi,Dong Kyun Kim,Yongho Shin,Ria Park,Yong-Yeon Cho,Joo Young Lee,Han Chang Kang,Hye Suk Lee
Molecules.2020;25(5)1254
[DOI]
81Differential Effects of p-Coumaric Acid in relieving Doxorubicin induced Cardiotoxicity in Solid Tumour Bearing and Non-tumor Bearing Mice
Sunitha Mary Chacko,R DhanyaKrishnan,Kottayath Govindan Nevin
Journal of Biologically Active Products from Nature.2021;11(2)138
[DOI]
82Ozone Attenuated H9c2 Cell Injury Induced by Doxorubicin
Lingshan Xu,Chenhao Wang,Zhiqing Zou,Zhouquan Wu
Journal of Cardiovascular Pharmacology.2021;78(1)e86
[DOI]
83A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer
Maolin Wang,Xing-sheng Shu,Meiqi Li,Yilin Zhang,Youli Yao,Xiaoyan Huang,Jianna Li,Pengfei Wei,Zhendan He,Jun Lu,Ying Ying
Frontiers in Oncology.2021;11(1)e86
[DOI]
84Protective Effect of miR-204 on Doxorubicin-Induced Cardiomyocyte Injury via HMGB1
Youyou Du,Guanghui Liu,Luosha Zhao,Rui Yao,Ding Sheng Jiang
Oxidative Medicine and Cellular Longevity.2020;2020(1)1
[DOI]
85Tailoring nanoparticles design for enhanced heating efficiency and improved magneto-chemo therapy for glioblastoma
Ruby Gupta,Tashmeen Kaur,Anjali Chauhan,Ravi Kumar,Bijoy K. Kuanr,Deepika Sharma
Biomaterials Advances.2022;139(1)213021
[DOI]
86Electrochemical Determination of Dexrazoxane by Differential Pulse Voltammetry (DPV) Using a Graphene Oxide Nanosheet Modified Pencil Graphite Electrode (PGE)
Fatma Akpinar,Kübra Gençdag Sensoy,Mihrican Muti
Analytical Letters.2022;139(1)1
[DOI]
87Thymoquinone attenuates doxorubicin-cardiotoxicity in rats
Derya Karabulut,Emel Ozturk,Emin Kaymak,Ali Tugrul Akin,Birkan Yakan
Journal of Biochemical and Molecular Toxicology.2021;35(1)1
[DOI]
88Signal transducer and activator of transcription 6 as a target in colon cancer therapy (Review)
Yael Delgado-Ramirez,Vaneesa Colly,Giovanni Villanueva Gonzalez,Sonia Leon-Cabrera
Oncology Letters.2020;20(1)455
[DOI]
89Liposomes for Intra-Articular Analgesic Drug Delivery in Orthopedics: State-of-Art and Future Perspectives. Insights from a Systematic Mini-Review of the Literature
Lucio Cipollaro,Paolo Trucillo,Nicola Luigi Bragazzi,Giovanna Della Porta,Ernesto Reverchon,Nicola Maffulli
Medicina.2020;56(9)423
[DOI]
90Os Efeitos da Doxorrubicina na Biossíntese e no Metabolismo do Heme em Cardiomiócitos
Zuoyan Wang,Junyi Gao,Haobo Teng,Jianjun Peng
Arquivos Brasileiros de Cardiologia.2021;116(2)315
[DOI]
91Phase-Change Material Packaged within Hollow Copper Sulfide Nanoparticles Carrying Doxorubicin and Chlorin e6 for Fluorescence-Guided Trimodal Therapy of Cancer
Qian Li,Lihong Sun,Mengmeng Hou,Qiubing Chen,Ruihao Yang,Lei Zhang,Zhigang Xu,Yuejun Kang,Peng Xue
ACS Applied Materials & Interfaces.2019;11(1)417
[DOI]
92Dual covalent functionalization of single-walled carbon nanotubes for effective targeted cancer therapy
Mohyeddin Assali,Naim Kittana,Safa’ Dayyeh,Noureddine Khiar
Nanotechnology.2021;32(20)205101
[DOI]
93Dual covalent functionalization of single-walled carbon nanotubes for effective targeted cancer therapy
Hatice Yildizhan,Nezehat Pinar Barkan,Seçil Karahisar Turan,Özerk Demiralp,Fatma Duygu Özel Demiralp,Bengi Uslu,Sibel A. Ozkan
Nanotechnology.2018;32(20)1
[DOI]
94Dual covalent functionalization of single-walled carbon nanotubes for effective targeted cancer therapy
Alaa A A Aljabali,Kaushik Pal,Rasha M. Bashatwah,Murtaza M. Tambuwala
Nanotechnology.2022;32(20)177
[DOI]
95A novel formulation of theranostic nanomedicine for targeting drug delivery to gastrointestinal tract cancer
Madeeha Shahzad Lodhi,Muhammad Tahir Khan,Saira Aftab,Zahoor Qadir Samra,Heng Wang,Dong Qing Wei
Cancer Nanotechnology.2021;12(1)177
[DOI]
96Decursin inAngelica gigasNakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression
Hyeong Sim Choi,Sung-Gook Cho,Min Kyoung Kim,Min Soo Kim,Seung Hee Moon,Il Hwan Kim,Seong-Gyu Ko
Phytotherapy Research.2016;30(12)2020
[DOI]
97Reduction of doxorubicin-induced cytotoxicity and mitochondrial damage by betanin in rat isolated cardiomyocytes and mitochondria
AA Hafez,Z Jamali,S Samiei,S Khezri,A Salimi
Human & Experimental Toxicology.2021;40(12)2123
[DOI]
98Reduction of doxorubicin-induced cytotoxicity and mitochondrial damage by betanin in rat isolated cardiomyocytes and mitochondria
Adityanarayan Mohapatra,Saji Uthaman,In-Kyu Park
Human & Experimental Toxicology.2019;40(12)205
[DOI]
99Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?
Mojtaba Mollaei,Zuhair Mohammad Hassan,Fatemeh Khorshidi,Ladan Langroudi
Translational Oncology.2021;14(5)101056
[DOI]
100Drug Delivery Approaches for Doxorubicin in the Management of Cancers
Manish Vyas,Daniel A. Simbo,Mohd. Mursalin,Vijay Mishra,Roqia Bashary,Gopal L. Khatik
Current Cancer Therapy Reviews.2020;16(4)320
[DOI]
101Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p
Xiaoxue Yu,Yang Ruan,Tao Shen,Quan Qiu,Mingjing Yan,Shenghui Sun,Lin Dou,Xiuqing Huang,Que Wang,Xiyue Zhang,Yong Man,Weiqing Tang,Zening Jin,Jian Li
BioMed Research International.2020;2020(4)1
[DOI]
102Bixin Prevents Colorectal Cancer Development through AMPK-Activated Endoplasmic Reticulum Stress
Yunfeng Qiu,Changfeng Li,Bin Zhang,Yue Gu
BioMed Research International.2022;2022(4)1
[DOI]
103The role of melatonin on chemotherapy-induced reproductive toxicity
Hamed Haghi-Aminjan,Mohammad Hossein Asghari,Bagher Farhood,Mahban Rahimifard,Nasser Hashemi Goradel,Mohammad Abdollahi
Journal of Pharmacy and Pharmacology.2018;70(3)291
[DOI]
104NUIG4: A biocompatible pcu metal–organic framework with an exceptional doxorubicin encapsulation capacity
Ahmed Ahmed,Constantinos G. Efthymiou,Rana Sanii,Ewa Patyk-Kazmierczak,Amir M. Alsharabasy,Meghan Winterlich,Naveen Kumar,Debobroto Sensharma,Wenming Tong,Sarah Guerin,Pau Farras,Sarah Hudson,Damien Thompson,Michael J. Zaworotko,Anastasios J. Tasiopoulos,Constantina Papatriantafyllopoulou
Journal of Materials Chemistry B.2022;10(9)1378
[DOI]
105?-Ray-Triggered Drug Release of Reactive Oxygen Species-Sensitive Nanomedicine for Enhanced Concurrent Chemoradiation Therapy
Ying Yu,Zujian Feng,Jinjian Liu,Xiaoxue Hou,Xiaoqian Zhou,Jie Gao,Wei Wang,Yumin Zhang,Guoliang Li,Jianfeng Liu
ACS Omega.2021;6(30)19445
[DOI]
106Mechanisms and Potential Treatment Options of Heart Failure in Patients With Multiple Myeloma
Ekaterina Proskuriakova,Keji Jada,Sandrine Kakieu Djossi,Anwar Khedr,Bandana Neupane,Jihan A Mostafa
Cureus.2021;6(30)19445
[DOI]
107Protective role of black seed oil in doxorubicin-induced cardiac toxicity in children with acute lymphoblastic leukemia
Adel A Hagag,Ibrahim M Badraia,Walid A El-Shehaby,Maaly M Mabrouk
Journal of Oncology Pharmacy Practice.2020;26(6)1397
[DOI]
108Preparation, characterization, and in vitro evaluation of amphiphilic peptide P12 and P12-DOX nanomicelles as antitumor drug carriers
Ping Song,Wuchen Du,Wanzhen Li,Longbao Zhu,Weiwei Zhang,Xinxing Gao,Yugui Tao,Fei Ge
Nanomaterials and Nanotechnology.2020;10(6)184798042091151
[DOI]
109Heterocyclic ring expansion yields anthraquinone derivatives potent against multidrug resistant tumor cells
Alexander S. Tikhomirov,Vladimir B. Tsvetkov,Yulia L. Volodina,Valeria A. Litvinova,Daria V. Andreeva,Lyubov G. Dezhenkova,Dmitry N. Kaluzhny,Ivan D. Treshalin,Alexander A. Shtil,Andrey E. Shchekotikhin
Bioorganic Chemistry.2022;127(6)105925
[DOI]
110Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma
Weijie Qiang,Yifei Dai,Xiaoyan Xing,Xiaobo Sun
Computational and Structural Biotechnology Journal.2021;19(6)1263
[DOI]
111Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma
Rutian Li,Xiaoping Qian
Computational and Structural Biotechnology Journal.2017;19(6)179
[DOI]
112Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy
Quan Liu,Yanhong Duo,Jianye Fu,Meng Qiu,Zhe Sun,Dickson Adah,Jianlong Kang,Zhongjian Xie,Taojian Fan,Shiyun Bao,Han Zhang,Li-Ping Liu,Yihai Cao
Nano Today.2021;36(6)101023
[DOI]
113MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition
Xiaoqing Guan,Shucheng Gu,Mu Yuan,Xiangxin Zheng,Ji Wu
Oncology Letters.2019;36(6)101023
[DOI]
114Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
Verena Schwach,Rolf H. Slaats,Robert Passier
Frontiers in Cardiovascular Medicine.2020;7(6)101023
[DOI]
115Perspectives and controversies regarding the use of natural products for the treatment of lung cancer
Tingting Wen,Lei Song,Shucheng Hua
Cancer Medicine.2021;10(7)2396
[DOI]
116Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders
Margarita E. Neganova,Yulia R. Aleksandrova,Olga A. Sukocheva,Sergey G. Klochkov
Seminars in Cancer Biology.2022;10(7)2396
[DOI]
117Establishment of childhood hepatoblastoma xenografts and evaluation of the anti-tumour effects of anlotinib, oxaliplatin and sorafenib
Dou Yang,Feng Chen,Dan Gong,Lei Zeng,Deng Xiang,Yuanqiao He,Leifeng Chen,Jinlong Yan,Shouhua Zhang
Pediatric Surgery International.2022;38(3)465
[DOI]
118Doxorubicin Exposure Affects Oocyte Meiotic Maturation through DNA Damage-Induced Meiotic Arrest
Zhi-Ming Ding,Shou-Xin Zhang,Xiao-Fei Jiao,Li-Ping Hua,Muhammad Jamil Ahmad,Di Wu,Fan Chen,Yong-Shang Wang,Xi-Yu Zhang,Fei Meng,Ze-Qun Duan,Yi-Liang Miao,Li-Jun Huo
Toxicological Sciences.2019;171(2)359
[DOI]
119Ameliorative effects of melatonin against solid Ehrlich carcinoma progression in female mice
Ali H. Amin,Mohamed A. El-Missiry,Azza I. Othman,Doaa A. Ali,Mona S. Gouida,Ahmed H. Ismail
Journal of Pineal Research.2019;67(2)359
[DOI]
120Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma
Yi Gao,Yue Zhu,Xiaopeng Xu,Fangjun Wang,Weidong Shen,Xia Leng,Jiyi Zhao,Bingtuan Liu,Yangyun Wang,Pengfei Liu
Frontiers in Cell and Developmental Biology.2021;9(2)359
[DOI]
121Structural, luminescence and geno/cytoxicity study of carbon dots derived from Opuntia ficus-indica (L.) Mill
Eduardo Madrigal-Bujaidar,Genaro Ivan Cerón-Montes,Joan Reyes-Miranda,Erasto Vergara-Hernández,Isela Álvarez-González,Ángel de Jesús Morales-Ramírez,Luis Enrique Francisco-Martínez,Aristeo Garrido-Hernández
New Journal of Chemistry.2020;44(3)942
[DOI]
122Two-dimensional materials in biomedical, biosensing and sensing applications
Nasuha Rohaizad,Carmen C. Mayorga-Martinez,Michaela Fojtu,Naziah M. Latiff,Martin Pumera
Chemical Society Reviews.2021;50(1)619
[DOI]
123The enrichment of cancer stem cells using composite alginate/polycaprolactone nanofibers
Wei-Wen Hu,Cheng-Hsien Lin,Zhen-Jie Hong
Carbohydrate Polymers.2019;206(1)70
[DOI]
124Treatment outcome of doxorubicin versus idarubicin in adult acute myeloid leukemia
Hemat Afifi Sherif,Ahmed Magdy,Heba Anees Elshesheni,Sherein Mahmoud Ramadan,Reham A. Rashed
Leukemia Research Reports.2021;16(1)100272
[DOI]
125Progress in drug-delivery systems in cardiovascular applications: stents, balloons and nanoencapsulation
Jaryl Chen Koon Ng,Daniel Wee Yee Toong,Valerie Ow,Su Yin Chaw,Hanwei Toh,Philip En Hou Wong,Subbu Venkatraman,Tze Tec Chong,Lay Poh Tan,Ying Ying Huang,Hui Ying Ang
Nanomedicine.2022;17(5)325
[DOI]
126Progress in drug-delivery systems in cardiovascular applications: stents, balloons and nanoencapsulation
Mariana Segovia-Mendoza,Cristina Lemini,Rocio García-Becerra,Jorge Morales-Montor
Nanomedicine.2021;17(5)11
[DOI]
127Dosimetric assessment of antitumor treatment by enhanced bleomycin delivery via electroporation and sonoporation
Martynas Maciulevicius,Mindaugas Tamošiunas,Rytis Jurkonis,Saulius Šatkauskas
Bioelectrochemistry.2022;146(5)108153
[DOI]
128The application of aluminium phthalocyanine AlPs-4-mediated photodynamic therapy against human soft tissue sarcoma (RMS) cell line
Muhammad Zakir,Ahmat Khurshid,Muhammad Iqbal Khan,Asma Khattak,Murad Ali Khan
Journal of Porphyrins and Phthalocyanines.2021;25(02)102
[DOI]
129Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma
Yongqiang Zhang,Yuqin Tang,Chengbin Guo,Gen Li
Aging.2021;13(9)12865
[DOI]
130Reticulocalbin-1 knockdown increases the sensitivity of cells to Adriamycin in nasopharyngeal carcinoma and promotes endoplasmic reticulum stress-induced cell apoptosis
Ze-Hao Huang,Jun Qiao,Yi-Yang Feng,Meng-Ting Qiu,Ting Cheng,Jia Wang,Chao-Feng Zheng,Zhi-Qin Lv,Cai-Hong Wang
Cell Cycle.2020;19(13)1576
[DOI]
131Immunomodulatory effects of bee pollen on doxorubicin-induced bone marrow/spleen immunosuppression in rat
Fayez Shaldoum,Attalla F. El-kott,Marwa Mohamed Ahmed Ouda,Eman M. Abd-Ella
Journal of Food Biochemistry.2021;45(6)1576
[DOI]
132Fatty acids: Adiposity and breast cancer chemotherapy, a bad synergy?
Ilze Mentoor,A-M Engelbrecht,Theo Nell
Prostaglandins, Leukotrienes and Essential Fatty Acids.2019;140(6)18
[DOI]
133Thymic function affects breast cancer development and metastasis by regulating expression of thymus secretions PTMa and Tß15b1
Dongling Shi,Yanmei Shui,Xie Xu,Kai He,Fengqing Yang,Jianli Gao
Translational Oncology.2021;14(1)100980
[DOI]
134Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients
Luigi Coltelli,Andrea Fontana,Sara Lucchesi,Laura Ginocchi,Guido Bocci,Mario Filidei,Marco Scalese,Giada Arrighi,Chiara Finale,Lorenzo Marcucci,Orlando Goletti,Barbara Salvadori,Ilaria Ferrarini,Eleonora Bona,Alfredo Falcone,Giacomo Allegrini
The Breast.2017;31(1)186
[DOI]
135In vitro irradiation of doxorubicin with 18F-FDG Cerenkov radiation and its potential application as a theragnostic system.
Hilda Angeline Quintos-Meneses,Liliana Aranda-Lara,Enrique Morales-Ávila,Eugenio Torres-García,Miguel Ángel Camacho-López,Mariana Sánchez-Holguín,Myrna A. Luna-Gutiérrez,Ninfa Ramírez-Durán,Keila Isaac-Olivé
Journal of Photochemistry and Photobiology B: Biology.2020;210(1)111961
[DOI]
136The implications of mitochondria in doxorubicin treatment of cancer in the context of traditional and modern medicine
Leonardo da Cunha Menezes Souza,Meng Chen,Yuji Ikeno,Daisy Maria Fávero Salvadori,Yidong Bai
Traditional Medicine and Modern Medicine.2020;03(04)239
[DOI]
137Loading of doxorubicin on poly(methyl methacrylate-co-methacrylic acid) nanoparticles and release study
Roberto López-Muñoz,María Esther Treviño,Fabiola Castellanos,Graciela Morales,Oliverio Rodríguez-Fernández,Santiago Saavedra,Angel Licea-Claverie,Hened Saade,Francisco Javier Enríquez-Medrano,Raúl Guillermo López
Journal of Biomaterials Science, Polymer Edition.2021;32(9)1107
[DOI]
138Impact of Doxorubicin on Cell-Substrate Topology
Andreas Krecsir,Verena Richter,Michael Wagner,Herbert Schneckenburger
International Journal of Molecular Sciences.2022;23(11)6277
[DOI]
139Low-intensity ultrasound enhances the antitumor effects of doxorubicin on hepatocellular carcinoma cells through the ROS-miR-21-PTEN axis
Chunhua Xia,Huabei Zeng,Yanfen Zheng
Molecular Medicine Reports.2020;23(11)6277
[DOI]
140Melatonin as an adjuvant treatment modality with doxorubicin
Parisa Maleki Dana,Fatemeh Sadoughi,Russel J. Reiter,Sotoudeh Mohammadi,Zahra Heidar,Masoumeh Mirzamoradi,Zatollah Asemi
Biochimie.2022;23(11)6277
[DOI]
141Alginate microbeads with internal microvoids for the sustained release of drugs
Stefania Boi,Nadia Rouatbi,Elena Dellacasa,Donatella Di Lisa,Paolo Bianchini,Orietta Monticelli,Laura Pastorino
International Journal of Biological Macromolecules.2020;156(11)454
[DOI]
142Quercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c-met
Yan Shu,Bo Xie,Zhen Liang,Jing Chen
Oncology Letters.2017;156(11)454
[DOI]
143Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac
Thangirala Sudha,Dhruba J Bharali,Murat Yalcin,Noureldien HE Darwish,Melis Debreli Coskun,Kelly A Keating,Hung-Yun Lin,Paul J Davis,Shaker A Mousa
Nanomedicine.2017;12(3)195
[DOI]
144Magnesium Fluoride Forms Unique Protein Corona for Efficient Delivery of Doxorubicin into Breast Cancer Cells
Hamed Al-Busaidi,Md. Karim,Syafiq Abidin,Kyi Tha,Ezharul Chowdhury
Toxics.2019;7(1)10
[DOI]
145The Effects of Bergamot Polyphenolic Fraction, Cynara cardunculus, and Olea europea L. Extract on Doxorubicin-Induced Cardiotoxicity
Jessica Maiuolo,Irene Bava,Cristina Carresi,Micaela Gliozzi,Vincenzo Musolino,Federica Scarano,Saverio Nucera,Miriam Scicchitano,Francesca Bosco,Stefano Ruga,Maria Caterina Zito,Francesca Oppedisano,Roberta Macri,Annamaria Tavernese,Rocco Mollace,Vincenzo Mollace
Nutrients.2021;13(7)2158
[DOI]
146Extracellular vesicles in cancer nanomedicine
Vadim V. Tarasov,Andrey A. Svistunov,Vladimir N. Chubarev,Samira A. Dostdar,Alexander V. Sokolov,Anna Brzecka,Olga Sukocheva,Margarita E. Neganova,Sergey G. Klochkov,Siva G. Somasundaram,Cecil E. Kirkland,Gjumrakch Aliev
Seminars in Cancer Biology.2021;69(7)212
[DOI]
147Genomic instability and cancer: lessons from Drosophila
Stephan U. Gerlach,Héctor Herranz
Open Biology.2020;10(6)200060
[DOI]
148Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation
Marco Pirisinu,Tin Chanh Pham,Daniel Xin Zhang,Tran Nguyen Hong,Lap Thi Nguyen,Minh TN Le
Seminars in Cancer Biology.2022;80(6)340
[DOI]
149Development of stimuli-responsive intelligent polymer micelles for the delivery of doxorubicin
Fan Yang,Jiangkang Xu,Manfei Fu,Jianbo Ji,Liqun Chi,Guangxi Zhai
Journal of Drug Targeting.2020;28(10)993
[DOI]
150Modification of graphene oxide by angiopep-2 enhances anti-glioma efficiency of the nanoscaled delivery system for doxorubicin
Yue Zhao,Hang Yin,Xiaoyu Zhang
Aging.2020;12(11)10506
[DOI]
151Composite-dissolving microneedle patches for chemotherapy and photothermal therapy in superficial tumor treatment
Peng Pei,Fan Yang,Jiaxing Liu,Haoran Hu,Xiaoyu Du,Nobutaka Hanagata,Shichang Zhao,Yufang Zhu
Biomaterials Science.2018;6(6)1414
[DOI]
152Tumor in 3D: In Vitro Complex Cellular Models to Improve Nanodrugs Cancer Therapy
Soraia Fernandes,Marco Cassani,Stefania Pagliari,Petr Filipensky,Francesca Cavalieri,Giancarlo Forte
Current Medicinal Chemistry.2020;27(42)7234
[DOI]
153A Review of Pharmacology, Toxicity and Pharmacokinetics of 2,3,5,4'-Tetrahydroxystilbene-2-O-ß-D-Glucoside
Cheng Wang,Shu Dai,Lihong Gong,Ke Fu,Cheng Ma,Yanfang Liu,Honglin Zhou,Yunxia Li
Frontiers in Pharmacology.2022;12(42)7234
[DOI]
154Advances in engineering local drug delivery systems for cancer immunotherapy
Peter Abdou,Zejun Wang,Qian Chen,Amanda Chan,Daojia R. Zhou,Vivienne Gunadhi,Zhen Gu
WIREs Nanomedicine and Nanobiotechnology.2020;12(5)7234
[DOI]
155Isoliquiritigenin ameliorates doxorubicin-induced acute pancreatitis by inhibiting ROS production via modulation of Nrf2/HO-1 oxidative stress pathway
Chen-Chen Yuan,Qing-Tian Zhu,Qin-Hao Shen,Xing-Meng Xu,Yao Xu,Qi Yang,Bai-Qiang Li,Guo-Tao Lu,Wei-Qin Li
World Chinese Journal of Digestology.2021;29(6)282
[DOI]
156Molecular relation between biological stress and carcinogenesis
Katarzyna Rakoczy,Wojciech Szlasa,Natalia Sauer,Jolanta Saczko,Julita Kulbacka
Molecular Biology Reports.2022;29(6)282
[DOI]
157Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma Therapy
Miguel Mateu-Sanz,Juan Tornín,Maria-Pau Ginebra,Cristina Canal
Journal of Clinical Medicine.2021;10(4)893
[DOI]
158The protective role of melatonin in chemotherapy-induced nephrotoxicity: a systematic review of non-clinical studies
Hamed Haghi-Aminjan,Bagher Farhood,Mahban Rahimifard,Tina Didari,Maryam Baeeri,Shokoufeh Hassani,Rohollah Hosseini,Mohammad Abdollahi
Expert Opinion on Drug Metabolism & Toxicology.2018;14(9)937
[DOI]
159Nodal increases the malignancy of childhood neuroblastoma cells via regulation of Zeb1
Jingfang Wu,Panpan Cheng,Zongxuan Huang,Qingshi Tan,Yuhua Qu
BioFactors.2019;45(3)355
[DOI]
160(-)-Epicatechin-3-gallate (a polyphenol from green tea) potentiates doxorubicin-induced apoptosis in H9C2 cardiomyocytes
Yi Cai,Hui-Qi Hong,Li Zhao,Yue-Peng Cai,Yuan Qin
Biotechnology Letters.2015;37(10)1937
[DOI]
161Cancer—A Major Cardiac Comorbidity With Implications on Cardiovascular Metabolism
Daniel Finke,Markus B. Heckmann,Norbert Frey,Lorenz H. Lehmann
Frontiers in Physiology.2021;12(10)1937
[DOI]
162Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect
Yawei Wang,Haiyan Zhang,Jing Hao,Bei Li,Ming Li,Wang Xiuwen
Drug Delivery.2016;23(4)1398
[DOI]
163The role of miRNAs in colorectal cancer progression and chemoradiotherapy
Ning Zhang,Xianyu Hu,Yinan Du,Juan Du
Biomedicine & Pharmacotherapy.2021;134(4)111099
[DOI]
164Matrix Metalloproteinase-9-Responsive Surface Charge-Reversible Nanocarrier to Enhance Endocytosis as Efficient Targeted Delivery System for Cancer Diagnosis and Therapy
Qiu-Ju Han,Xiao-Tong Lan,Ying Wen,Chuan-Zeng Zhang,Michael Cleary,Yasra Sayyed,Guangdong Huang,Xiaoling Tuo,Long Yi,Zhen Xi,Lu-Yuan Li,Qiang-Zhe Zhang
Advanced Healthcare Materials.2021;10(9)2002143
[DOI]
165Ginsenoside F1 attenuates pirarubicin-induced cardiotoxicity by modulating Nrf2 and AKT/Bcl-2 signaling pathways
Yang Zhang,Jiulong Ma,Shan Liu,Chen Chen,Qi Li,Meng Qin,Liqun Ren
Journal of Ginseng Research.2022;10(9)2002143
[DOI]
166Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy
Marina Curra,Amanda F. Gabriel,Maria Beatriz C. Ferreira,Marco Antonio T. Martins,André T. Brunetto,Lauro J. Gregianin,Manoela Domingues Martins
Supportive Care in Cancer.2021;29(11)6243
[DOI]
167Polyethylenimine–Bisphosphonate–Cyclodextrin Ternary Conjugates: Supramolecular Systems for the Delivery of Antineoplastic Drugs
Simona Plesselova,Pablo Garcia-Cerezo,Victor Blanco,Francisco J. Reche-Perez,Fernando Hernandez-Mateo,Francisco Santoyo-Gonzalez,María Dolores Giron-Gonzalez,Rafael Salto-Gonzalez
Journal of Medicinal Chemistry.2021;64(16)12245
[DOI]
168Greenness estimation of chromatographic assay for the determination of anthracycline-based antitumor drug in bacterial ghost matrix of Salmonella typhimurium
Nazrul Haq,Fars K. Alanazi,Mounir M. Salem-Bekhit,Sameh Rabea,Prawez Alam,Ibrahim A. Alsarra,Faiyaz Shakeel
Sustainable Chemistry and Pharmacy.2022;26(16)100642
[DOI]
169Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper
Nina Rosa Neuendorff,Kah Poh Loh,Alice S. Mims,Konstantinos Christofyllakis,Wee-Kheng Soo,Bediha Bölükbasi,Carlos Oñoro-Algar,William G. Hundley,Heidi D. Klepin
Blood Advances.2020;4(4)762
[DOI]
170DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy
Larissa Costa de Almeida,Felipe Antunes Calil,João Agostinho Machado-Neto,Leticia Veras Costa-Lotufo
Cancer Genetics.2021;252-253(4)6
[DOI]
171Cariporide Attenuates Doxorubicin-Induced Cardiotoxicity in Rats by Inhibiting Oxidative Stress, Inflammation and Apoptosis Partly Through Regulation of Akt/GSK-3ß and Sirt1 Signaling Pathway
Wenli Liao,Zhiwei Rao,Lingling Wu,Yong Chen,Cairong Li
Frontiers in Pharmacology.2022;13(4)6
[DOI]
172The Basement Membrane in a 3D Breast Acini Model Modulates Delivery and Anti-Proliferative Effects of Liposomal Anthracyclines
Tabea Wiedenhoeft,Tobias Braun,Ronald Springer,Michael Teske,Erik Noetzel,Rudolf Merkel,Agnes Csiszár
Pharmaceuticals.2020;13(9)256
[DOI]
173Differential toxicity of gold-doxorubicin in cancer cells vs. cardiomyocytes as measured by real-time growth assays and fluorescence lifetime imaging microscopy (FLIM)
Eric Tawagi,Charlotte Massmann,Hicham Chibli,Jay L. Nadeau
The Analyst.2015;140(16)5732
[DOI]
174The Use of Phospholipids to Make Pharmaceutical Form Line Extensions
Peter Hoogevest,Harry Tiemessen,Josbert M. Metselaar,Simon Drescher,Alfred Fahr
European Journal of Lipid Science and Technology.2021;123(4)2000297
[DOI]
175Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma
Soniya Kumbham,Milan Paul,Asif Itoo,Balaram Ghosh,Swati Biswas
International Journal of Pharmaceutics.2022;614(4)121479
[DOI]
176Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway
Bai-liang Ye,Ru Zheng,Xiao-jiao Ruan,Zhi-hai Zheng,Hua-jie Cai
Biochemical and Biophysical Research Communications.2018;495(1)414
[DOI]
177Nanoliposomes in Cancer Therapy: Marketed Products and Current Clinical Trials
Raquel Taléns-Visconti,Octavio Díez-Sales,Jesus Vicente de Julián-Ortiz,Amparo Nácher
International Journal of Molecular Sciences.2022;23(8)4249
[DOI]
178Breast cancer: Muscarinic receptors as new targets for tumor therapy
Alejandro Español,Agustina Salem,Yamila Sanchez,María Elena Sales
World Journal of Clinical Oncology.2021;12(6)404
[DOI]
179Evaluation of Anti-Cancer Effects of Caspian Cobra (Naja naja oxiana) Snake Venom in Comparison with Doxorubicin in HeLa Cancer Cell Line and Normal HFF Fibroblast
Fatemeh Javani Jouni,Jaber Zafari,Elaheh Shams,Parviz Abdolmaleki,Ali asghar Rastegari
journal of ilam university of medical sciences.2021;29(6)20
[DOI]
180A Review on Drug Delivery System for Tumor Therapy
Guoxiang Liu,Lina Yang,Guang Chen,Fenghua Xu,Fanghao Yang,Huaxin Yu,Lingne Li,Xiaolei Dong,Jingjing Han,Can Cao,Jingyu Qi,Junzhe Su,Xiaohui Xu,Xiaoxia Li,Bing Li
Frontiers in Pharmacology.2021;12(6)20
[DOI]
181Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment
Haoyu Li,Zhenghu Chen,Ting Hu,Long Wang,Yang Yu,Yanling Zhao,Wenijing Sun,Shan Guan,Jonathan C. Pang,Sarah E. Woodfield,Qing Liu,Jianhua Yang
Scientific Reports.2016;6(1)20
[DOI]
182Copolymacrolactones Grafted with l-Glutamic Acid: Synthesis, Structure, and Nanocarrier Properties
Ernesto Tinajero-Díaz,Antxon Martínez de Ilarduya,Sebastián Muñoz-Guerra
Polymers.2020;12(4)995
[DOI]
183Diosmin Alleviates Doxorubicin-Induced Liver Injury via Modulation of Oxidative Stress-Mediated Hepatic Inflammation and Apoptosis via NfkB and MAPK Pathway: A Preclinical Study
Abdullah F. AlAsmari,Metab Alharbi,Faleh Alqahtani,Fawaz Alasmari,Mohammed AlSwayyed,Sami I. Alzarea,Ibrahim A. Al-Alallah,Adel Alghamdi,Hassan M. Hakami,Meshal K. Alyousef,Youssef Sari,Nemat Ali
Antioxidants.2021;10(12)1998
[DOI]
184Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development
Shankar Swaminathan,Roberta Cavalli,Francesco Trotta
WIREs Nanomedicine and Nanobiotechnology.2016;8(4)579
[DOI]
185Hepatoprotective potential of the n-butanol extract of Moricandia arvensis from Algeria against doxorubicin induced toxicity in Wistar albino rats
Meriem Laraba,Sana Hazar Tachour,Hanene Belbache,Nassima Boubekri,Radja Djebbari,Fadila Benayache,Samir Benayache,Djamila Zama
Advances in Traditional Medicine.2022;8(4)579
[DOI]
186Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy
Chang Yang,Yu Jiang,Sai Heng Hao,Xing Yi Yan,De Fei Hong,Hua Naranmandura
Journal of Materials Chemistry B.2022;10(1)20
[DOI]
187Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study
Soo Jin Park,Jihye Kim,Hee Seung Kim,Jeong-Won Lee,Ha Kyun Chang,Keun Ho Lee,Dae-Yeon Kim,Sunghoon Kim,Suk-Joon Chang,Seung Su Han,Sang-Yoon Park,Seung-Hyuk Shim
Journal of Gynecologic Oncology.2020;31(2)20
[DOI]
188Updates in Anthracycline-Mediated Cardiotoxicity
Canan G. Nebigil,Laurent Désaubry
Frontiers in Pharmacology.2018;9(2)20
[DOI]
189Synergetic effect of adsorption-photocatalysis by GO-CeO2nanocomposites for photodegradation of doxorubicin
M. Ali Abbasi,Khaled M. Amin,Mubarak Ali,Zulqurnain Ali,Muhammad Atif,Wolfgang Ensinger,Waqas Khalid
Journal of Environmental Chemical Engineering.2022;10(1)107078
[DOI]
190Evaluation of Cytotoxicity Induced by the Anti-Cancerous Drugs Doxorubicin and Erlotinib in Allium cepa Assay for Eco-Safety Monitoring
Debadrito Das,Prashanta Kumar Mitra,Sudha Gupta
CYTOLOGIA.2021;86(3)195
[DOI]
191Doxorubicin delivery systems with an acetylacetone-based block in cholesterol-terminated copolymers: Diverse activity against estrogen-dependent and estrogen-independent breast cancer cells
Pawel Misiak,Katarzyna Niemirowicz-Laskowska,Iwona Misztalewska-Turkowicz,Karolina H. Markiewicz,Przemyslaw Wielgat,Halina Car,Agnieszka Z. Wilczewska
Chemistry and Physics of Lipids.2022;245(3)105194
[DOI]
192Engineering Chemotherapeutic-Augmented Calcium Phosphate Nanoparticles for Treatment of Intraperitoneal Disseminated Ovarian Cancer
Miaojuan Qiu,Junzong Chen,Xiuyu Huang,Binbin Li,Shiqiang Zhang,Peng Liu,Qiang Wang,Zhi Rong Qian,Yihang Pan,Yu Chen,Jing Zhao
ACS Applied Materials & Interfaces.2022;14(19)21954
[DOI]
193Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
Li Chen,Chao Wang,Ning Hu,Hongmian Zhao
RSC Advances.2019;9(2)1004
[DOI]
194Effect of TAT-DOX-PEG irradiated gold nanoparticles conjugates on human osteosarcoma cells
Raoul V. Lupusoru,Daniela A. Pricop,Cristina M. Uritu,Adina Arvinte,Adina Coroaba,Irina Esanu,Mirela F. Zaltariov,Mihaela Silion,Cipriana Stefanescu,Mariana Pinteala
Scientific Reports.2020;10(1)1004
[DOI]
195Citrate- and Succinate-Modified Carbonate Apatite Nanoparticles with Loaded Doxorubicin Exhibit Potent Anticancer Activity against Breast Cancer Cells
Ezharul Chowdhury
Pharmaceutics.2018;10(1)32
[DOI]
196Toxicity of Carbon Nanomaterials and Their Potential Application as Drug Delivery Systems: In Vitro Studies in Caco-2 and MCF-7 Cell Lines
Rosa Garriga,Tania Herrero-Continente,Miguel Palos,Vicente L. Cebolla,Jesús Osada,Edgar Muñoz,María Jesús Rodríguez-Yoldi
Nanomaterials.2020;10(8)1617
[DOI]
197Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice
Bryan Oronsky,Eilleen S. Y. Ao-Ieong,Ozlem Yalcin,Corey A. Carter,Pedro Cabrales
Molecular Pharmaceutics.2019;16(7)2929
[DOI]
198Graphene oxide as a potential drug carrier – Chemical carrier activation, drug attachment and its enzymatic controlled release
Anna Trusek,Edward Kijak,Ludomira Granicka
Materials Science and Engineering: C.2020;116(7)111240
[DOI]
199Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling
Entaz Bahar,Ji-Ye Kim,Hyonok Yoon
Cancers.2019;11(3)338
[DOI]
200Active Targeting of Cancer Cells by Nanobody Decorated Polypeptide Micelle with Bio-orthogonally Conjugated Drug
Simone A. Costa,Davoud Mozhdehi,Michael J. Dzuricky,Farren J. Isaacs,Eric M. Brustad,Ashutosh Chilkoti
Nano Letters.2019;19(1)247
[DOI]
201Cytoprotective Effects of Dinitrosyl Iron Complexes on Viability of Human Fibroblasts and Cardiomyocytes
Natalia Pavlovna Akentieva,Natalia Alekseevna Sanina,Artur Rasimovich Gizatullin,Natalia Ivanovna Shkondina,Tatyana Romanovna Prikhodchenko,Stanislav Ivanovich Shram,Nikolai Zhelev,Sergei Michailovich Aldoshin
Frontiers in Pharmacology.2019;10(1)247
[DOI]
202Doxorubicin suppresses chondrocyte differentiation by stimulating ROS production
Cheng Wu,Jiayi Luo,Yuanxin Liu,Jiannan Fan,Xianwen Shang,Riguang Liu,Chuan Ye,Jihong Yang,Hong Cao
European Journal of Pharmaceutical Sciences.2021;167(1)106013
[DOI]
203Thymoquinone has a neuroprotective effect against inflammation, oxidative stress, and endoplasmic reticulum stress in the brain cortex, medulla, and hippocampus due to doxorubicin
Emin Kaymak,Ali Tugrul Akin,Emel Öztürk,Derya Karabulut,Nurhan Kuloglu,Birkan Yakan
Journal of Biochemical and Molecular Toxicology.2021;35(11)106013
[DOI]
204A proteomic analysis of an in vitro knock-out of miR-200c
Bojan Ljepoja,Jonathan García-Roman,Ann-Katrin Sommer,Thomas Fröhlich,Georg J. Arnold,Ernst Wagner,Andreas Roidl
Scientific Reports.2018;8(1)106013
[DOI]
205Mass spectrometric approaches for the identification of anthracycline analogs produced by actinobacteria
Anelize Bauermeister,Tiago Domingues Zucchi,Luiz Alberto Beraldo Moraes
Journal of Mass Spectrometry.2016;51(6)437
[DOI]
206miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer
Hui Zhang,Xiao-Dong Zheng,Xiao-Hua Zeng,Li Li,Qi Zhou
YAKUGAKU ZASSHI.2021;141(3)415
[DOI]
207Mechanism-Based Sonodynamic–Chemo Combinations against Triple-Negative Breast Cancer
Xiaolan Feng,Chen Wu,Wenhao Yang,Jiayi Wu,Pan Wang
International Journal of Molecular Sciences.2022;23(14)7981
[DOI]
208Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy
Shuai Guo,Yafei Chen,Sai Shi,Xuzhao Wang,Hailin Zhang,Yong Zhan,Hailong An
Pharmacological Research.2020;155(14)104721
[DOI]
209Chemotherapeutic Regimens and Chemotherapy-Free Intervals Influence the Survival of Patients with Recurrent Advanced Epithelial Ovarian Carcinoma: A Retrospective Population-Based Study
Hsin-Ying Huang,Chun-Ju Chiang,Yun-Yuan Chen,San-Lin You,Heng-Cheng Hsu,Chao-Hsiun Tang,Wen-Fang Cheng
International Journal of Environmental Research and Public Health.2021;18(12)6629
[DOI]
210Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis
Yumei Bai,Yanghua Li,Juan Bai,Yumei Zhang
Journal of Orthopaedic Surgery and Research.2021;16(1)6629
[DOI]
211Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy
Wei Guo,Yuanyuan Song,Wantong Song,Yingmin Liu,Zhihe Liu,Dawei Zhang,Zhaohui Tang,Ou Bai
Scientific Reports.2020;10(1)6629
[DOI]
212Current Insights into Cellular Senescence and Myotoxicity Induced by Doxorubicin: The Role of Exercise and Growth Factors
Charalampos Andreou,Antonios Matsakas
International Journal of Sports Medicine.2022;10(1)6629
[DOI]
213Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects
Haroon Khan,Hammad Ullah,Miquel Martorell,Susana Esteban Valdes,Tarun Belwal,Silvia Tejada,Antoni Sureda,Mohammad Amjad Kamal
Seminars in Cancer Biology.2021;69(1)200
[DOI]
2142D Germanane Derivative as a Vector for Overcoming Doxorubicin Resistance in Cancer Cells
Michaela Fojtu,Jan Balvan,Martina Raudenská,Tomáš Vicar,Jirí Šturala,Zdenek Sofer,Jan Luxa,Jan Plutnar,Michal Masarík,Martin Pumera
Applied Materials Today.2020;20(1)100697
[DOI]
215Sensitive analysis of doxorubicin and curcumin by micellar electromagnetic chromatography with a double wavelength excitation source
Xiao Yu,Wanxiang Yu,Xiufen Han,Zuanguang Chen,Shumei Wang,Haiyun Zhai
Analytical and Bioanalytical Chemistry.2021;413(2)469
[DOI]
216Melatonin as an adjuvant treatment modality with doxorubicin [Biochimie 200 (2022) 1–7]
Parisa Maleki Dana,Fatemeh Sadoughi,Russel J. Reiter,Sotoudeh Mohammadi,Zahra Heidar,Masoumeh Mirzamoradi,Zatollah Asemi
Biochimie.2022;200(2)1
[DOI]
217Chemoresistance: Intricate Interplay Between Breast Tumor Cells and Adipocytes in the Tumor Microenvironment
Ilze Mentoor,Anna-Mart Engelbrecht,Paul J. van Jaarsveld,Theo Nell
Frontiers in Endocrinology.2018;9(2)1
[DOI]
218AIE-Based Fluorescent Triblock Copolymer Micelles for Simultaneous Drug Delivery and Intracellular Imaging
Bhagyashree Kulkarni,Somayah Qutub,Viko Ladelta,Niveen M. Khashab,Nikos Hadjichristidis
Biomacromolecules.2021;22(12)5243
[DOI]
219Doxorubicin delivery by polymer nanocarrier based on N-methylglucamine resorcinarene
Tatiana Yu. Sergeeva,Rezeda K. Mukhitova,Leysan R. Bakhtiozina,Irek R. Nizameev,Marsil K. Kadirov,Anastasia S. Sapunova,Alexandra D. Voloshina,Albina Y. Ziganshina,Igor S. Antipin
Supramolecular Chemistry.2020;32(2)150
[DOI]
220Doxorubicin delivery by polymer nanocarrier based on N-methylglucamine resorcinarene
Francesca Felicia Caputi,Sanzio Candeletti,Patrizia Romualdi
Supramolecular Chemistry.2017;32(2)150
[DOI]
221Platelet-rich plasma inhibits Adriamycin-induced inflammation via blocking the NF-?B pathway in articular chondrocytes
Haijun Zhao,Weijie Zhu,Wude Mao,Chengkai Shen
Molecular Medicine.2021;27(1)150
[DOI]
222Miniatured Fluidics-Mediated Modular Self-Assembly of Anticancer Drug–Amino Acid Composite Microbowls for Combined Chemo-Photodynamic Therapy in Glioma
Sonika Chibh,Vibhav Katoch,Manish Singh,Bhanu Prakash,Jiban Jyoti Panda
ACS Biomaterials Science & Engineering.2021;7(12)5654
[DOI]
223A bioimaging system combining human cultured reporter cells and planar chromatography to identify novel bioactive molecules
Ines Klingelhöfer,Long Pham Ngoc,Bart van der Burg,Gertrud E. Morlock
Analytica Chimica Acta.2021;1183(12)338956
[DOI]
224Protective effects and mechanism of coenzyme Q10 and vitamin C on doxorubicin-induced gastric mucosal injury and effects of intestinal flora
Xiaomeng Zhao,Xueke Feng,Nan Ye,Panpan Wei,Zhanwei Zhang,Wenyu Lu
The Korean Journal of Physiology & Pharmacology.2021;25(4)261
[DOI]
225Substrate Scope of O-Methyltransferase from Streptomyces peucetius for Biosynthesis of Diverse Natural Products Methoxides
Prakash Parajuli,Ramesh Prasad Pandey,Thi Huyen Trang Nguyen,Dipesh Dhakal,Jae Kyung Sohng
Applied Biochemistry and Biotechnology.2018;184(4)1404
[DOI]
226Dual-Targeted Hyaluronic Acid/Albumin Micelle-Like Nanoparticles for the Vectorization of Doxorubicin
Manuela Curcio,Luis Diaz-Gomez,Giuseppe Cirillo,Fiore Pasquale Nicoletta,Antonella Leggio,Francesca Iemma
Pharmaceutics.2021;13(3)304
[DOI]
227Application of new multicomponent nanosystems for overcoming doxorubicin resistance in breast cancer therapy
Nataliya Kutsevol,Yuliia Kuziv,Tetiana Bezugla,Pavlo Virych,Andrii Marynin,Tetiana Borikun,Natalia Lukianova,Petro Virych,Vasyl Chekhun
Applied Nanoscience.2022;12(3)427
[DOI]
228Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity
You-Ping Wu,Sheng Zhang,Yan-Fei Xin,Li-Qiang Gu,Xiao-Zhen Xu,Cheng-Da Zhang,Zhen-Qiang You
Phytomedicine.2021;88(3)153597
[DOI]
229Combining ultrasound and intratumoral administration of doxorubicin-loaded microspheres to enhance tumor cell killing
Anh-Vu Do,Sean M. Geary,Dongrim Seol,Philip Tobias,Daniel Carlsen,Nattawut Leelakanok,James A. Martin,Aliasger K. Salem
International Journal of Pharmaceutics.2018;539(1-2)139
[DOI]
230The protective effect of ethanol leaf extract of Annona muricata against doxorubicin toxicity via modulations of hematological, serum biochemical, antioxidant enzymes, and lipid peroxidation
Badmus JA,Rafiu MA,Fatoki JO
Phytomedicine Plus.2022;2(3)100328
[DOI]
231Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation
Ahu Yorulmaz,Mutlu Dogan,Ferda Artuz,Nurullah Zengin
Cutaneous and Ocular Toxicology.2017;36(2)135
[DOI]
232Role of Creatine in the Heart: Health and Disease
Maurizio Balestrino
Nutrients.2021;13(4)1215
[DOI]
233Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1
Sheng Zhang,Peng Wu,Jiabao Liu,Yingqiang Du,Zhijian Yang
Drug Design, Development and Therapy.2021;Volume 15(4)87
[DOI]
234Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1
Paramita Paul,Sanchita Mandal,Tarun Kumar Dua,Dipika Mandal,R Manasa Deepa
Drug Design, Development and Therapy.2021;Volume 15(4)177
[DOI]
235Pluronic P123 modified nano micelles loaded with doxorubicin enhanced tumor-suppressing effect on drug-resistant breast cancer cells
Xiaoyu Zhang,Weibin Chen,Jie Bai,Lijun Jin,Xiaoning Kang,Hui Zhang,Zunyi Wang
Aging.2020;12(9)8289
[DOI]
236Ribosomal protein L5 mediated inhibition of c-Myc is critically involved in sanggenon G induced apoptosis in non-small lung cancer cells
Ji Eon Park,Ji Hoon Jung,Hyo-Jung Lee,Deok Yong Sim,Eunji Im,Woon Yi Park,Bum Sang Shim,Seong-Gyu Ko,Sung-Hoon Kim
Phytotherapy Research.2021;35(2)1080
[DOI]
237Intracellular RNA and nuclear DNA-dual-targeted tumor therapy via upconversion nanoplatforms with UCL/MR dual-mode bioimaging
Bo Teng,Binbin Ding,Shuai Shao,Zhanfeng Wang,Weifang Tong,Sanchun Wang,Ziyong Cheng,Jun Lin,Ping'an Ma
Chemical Engineering Journal.2021;405(2)126606
[DOI]
238Sex Differences in Cancer: Epidemiology, Genetics and Therapy
Hae-In Kim,Hyesol Lim,Aree Moon
Biomolecules & Therapeutics.2018;26(4)335
[DOI]
239Preparation and in vitro/in vivo evaluation of doxorubicin-loaded poly[lactic-co-glycol acid] microspheres using electrospray method for sustained drug delivery and potential intratumoral injection
Ming-Yi Hsu,Yu-Ting Huang,Chun-Jui Weng,Chien-Ming Chen,Yong-Fong Su,Sung-Yu Chu,Jeng-Hwei Tseng,Ren-Chin Wu,Shih-Jung Liu
Colloids and Surfaces B: Biointerfaces.2020;190(4)110937
[DOI]
240Circ-SKA3 Enhances Doxorubicin Toxicity in AC16 Cells Through miR-1303/TLR4 Axis
Bin Li,Xinyong Cai,Yunxia Wang,Hongmin Zhu,Ping Zhang,Panpan Jiang,Xu Yang,Jianhua Sun,Lang Hong,Liang Shao
International Heart Journal.2021;62(5)1112
[DOI]
241Fabrication of 6-gingerol, doxorubicin and alginate hydroxyapatite into a bio-compatible formulation: enhanced anti-proliferative effect on breast and liver cancer cells
Danushika C. Manatunga,Rohini M. de Silva,K. M. Nalin de Silva,Dulharie T. Wijeratne,Gathsaurie Neelika Malavige,Gareth Williams
Chemistry Central Journal.2018;12(1)1112
[DOI]
242Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines
Michela Levi,Roberta Salaroli,Federico Parenti,Raffaella De Maria,Augusta Zannoni,Chiara Bernardini,Cecilia Gola,Antonio Brocco,Asia Marangio,Cinzia Benazzi,Luisa Vera Muscatello,Barbara Brunetti,Monica Forni,Giuseppe Sarli
BMC Veterinary Research.2021;17(1)1112
[DOI]
243Optical properties of natural small molecules and their applications in imaging and nanomedicine
Hao Yuan,Ao Jiang,Hongbao Fang,Yuncong Chen,Zijian Guo
Advanced Drug Delivery Reviews.2021;179(1)113917
[DOI]
244Preparation and characterization of PEGylated liposomal Doxorubicin targeted with leptin-derived peptide and evaluation of their anti-tumor effects, in vitro and in vivo in mice bearing C26 colon carcinoma
Naghmeh Shahraki,Amin Mehrabian,Shahrazad Amiri-Darban,Seyedeh Alia Moosavian,Mahmoud Reza Jaafari
Colloids and Surfaces B: Biointerfaces.2021;200(1)111589
[DOI]
245Apocynum venetum leaf extract alleviated doxorubicin-induced cardiotoxicity through the AKT/Bcl-2 signaling pathway
Yang Zhang,Shan Liu,Jiu-Long Ma,Chen Chen,Peng Huang,Jia-Hua Ji,Di Wu,Li-Qun Ren
Phytomedicine.2022;94(1)153815
[DOI]
246Characterization of Caerulomycin A as a dual-targeting anticancer agent
Lingying Tong,Weichao Sun,Shiyong Wu,Yong Han
European Journal of Pharmacology.2022;922(1)174914
[DOI]
247New molecular and biochemical insights of doxorubicin-induced hepatotoxicity
Pureti Lakshmi Prasanna,Kaviyarasi Renu,Abilash Valsala Gopalakrishnan
Life Sciences.2020;250(1)117599
[DOI]
248Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity
Yuewen Wang,Xu Chao,Fiaz ud Din Ahmad,Hailong Shi,Hania Mehboob,Waseem Hassan
Cardiology Research and Practice.2019;2019(1)1
[DOI]
249Regulatory role of the transforming growth factor-ß signaling pathway in the drug resistance of gastrointestinal cancers
Xiaoqun Lv,Guoxiong Xu
World Journal of Gastrointestinal Oncology.2021;13(11)1648
[DOI]
250Doxorubicin-Based Hybrid Compounds as Potential Anticancer Agents: A Review
Sijongesonke Peter,Sibusiso Alven,Rejoice Bethusile Maseko,Blessing Atim Aderibigbe
Molecules.2022;27(14)4478
[DOI]
251Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma
Yang Liu,Deepak Bushan Raina,Sujeesh Sebastian,Harshitha Nagesh,Hanna Isaksson,Jacob Engellau,Lars Lidgren,Magnus Tägil
Acta Biomaterialia.2021;131(14)555
[DOI]
252Bioequivalence of a hybrid pegylated liposomal doxorubicin hydrochloride injection and Caelyx®: A single-dose, randomized, multicenter, open-label, two-period crossover study in patients with advanced ovarian cancer
Prakash S. S.,Rajnish Vasant Nagarkar,Krishna Chaitanya Puligundla,Lokesh K. N.,Rakesh Reddy Boya,Ankit Baldevbhai Patel,Lovenish Goyal,Aniket Thoke,Jigar Gordhanbhai Patel,Ajay Omprakash Mehta,Ghanshyam Nanubhai Patel,Mujtaba A. Khan,Imran Ahmad
European Journal of Pharmaceutical Sciences.2022;176(14)106248
[DOI]
253MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma
Pengxuan Zhao,Shuangping Wu,Yao Cheng,Jia You,Yan Chen,Minsi Li,Chuanchuan He,Xiaojuan Zhang,Tan Yang,Yao Lu,Robert J. Lee,Xingxing He,Guangya Xiang
Nanomedicine: Nanotechnology, Biology and Medicine.2017;13(8)2507
[DOI]
254Extracts of Bridelia ovata and Croton oblongifolius induce apoptosis in human MDA-MB-231 breast cancer cells via oxidative stress and mitochondrial pathways
Juthathip Poofery,Bungorn Sripanidkulchai,Ratana Banjerdpongchai
International Journal of Oncology.2020;13(8)2507
[DOI]
255Emerging molecular mechanisms in chemotherapy: Ca2+ signaling at the mitochondria-associated endoplasmic reticulum membranes
Martijn Kerkhofs,Mart Bittremieux,Giampaolo Morciano,Carlotta Giorgi,Paolo Pinton,Jan B. Parys,Geert Bultynck
Cell Death & Disease.2018;9(3)2507
[DOI]
256Design and optimization of PEGylated silver nanoparticles for efficient delivery of doxorubicin to cancer cells
Ahmed Abdelfattah,Ahmed E. Aboutaleb,Abu-Baker M. Abdel-Aal,Ahmed A.H. Abdellatif,Hesham M. Tawfeek,Sayed I. Abdel-Rahman
Journal of Drug Delivery Science and Technology.2022;71(3)103347
[DOI]
257Heart failure and chemotherapeutic agents
Susan Piper,Theresa McDonagh
Future Cardiology.2015;11(4)453
[DOI]
258Enhanced therapeutic index of liposomal doxorubicin Myocet locally delivered by fibrin gels in immunodeficient mice bearing human neuroblastoma
Maurizio Viale,Vittorio Bertone,Irena Maric,Michele Cilli,Laura Emionite,Vittorio Bocchini,Mirco Ponzoni,Vincenzo Fontana,Fabrizio De Luca,Mattia Rocco
Pharmacological Research.2021;163(4)105294
[DOI]
259Formulation of liposomes functionalized with Lotus lectin and effective in targeting highly proliferative cells
Cinzia Della Giovampaola,Antonietta Capone,Leonardo Ermini,Pietro Lupetti,Elisa Vannuccini,Federica Finetti,Sandra Donnini,Marina Ziche,Agnese Magnani,Gemma Leone,Claudio Rossi,Floriana Rosati,Claudia Bonechi
Biochimica et Biophysica Acta (BBA) - General Subjects.2017;1861(4)860
[DOI]
260Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells
Ujjwal Joshi,Nina Filipczak,Muhammad Muzamil Khan,Sara Aly Attia,Vladimir Torchilin
International Journal of Pharmaceutics.2020;590(4)119915
[DOI]
261Design and Synthesis of Multi-Functional Superparamagnetic Core-Gold Shell Nanoparticles Coated with Chitosan and Folate for Targeted Antitumor Therapy
Sharafaldin Al-Musawi,Salim Albukhaty,Hassan Al-Karagoly,Faizah Almalki
Nanomaterials.2020;11(1)32
[DOI]
262Thioredoxin-1 Activation by Pterostilbene Protects Against Doxorubicin-Induced Hepatotoxicity via Inhibiting the NLRP3 Inflammasome
Shiqing Tan,Jie Bai,Mingxi Xu,Longying Zhang,Ying Wang
Frontiers in Pharmacology.2022;13(1)32
[DOI]
263Hydrazone modified nanoscale metal-organic frameworks as pH responsive nanoplatforms for cancer therapy
Datian Fu,Yan Wang,Jin Xu,Haimei Wu
Journal of Solid State Chemistry.2022;310(1)123029
[DOI]
264Preclinical studies of the antitumor effect of curcumin-loaded polymeric nanocapsules: A systematic review and meta-analysis
Thayse V. de Oliveira,Renan Stein,Diego F. de Andrade,Ruy C. R. Beck
Phytotherapy Research.2022;36(8)3202
[DOI]
265Smart Lipid–Polysaccharide Nanoparticles for Targeted Delivery of Doxorubicin to Breast Cancer Cells
Manuela Curcio,Matteo Brindisi,Giuseppe Cirillo,Luca Frattaruolo,Antonella Leggio,Vittoria Rago,Fiore Pasquale Nicoletta,Anna Rita Cappello,Francesca Iemma
International Journal of Molecular Sciences.2022;23(4)2386
[DOI]
266Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity
Sonja Dragojevic,Jung Su Ryu,Michael E. Hall,Drazen Raucher
Molecules.2022;27(11)3371
[DOI]
267NMR based model of human telomeric repeat G-quadruplex in complex with 2,4,6-triarylpyridine family ligand
Abdelaziz Kerkour,Jean-Louis Mergny,Gilmar F. Salgado
Biochimica et Biophysica Acta (BBA) - General Subjects.2017;1861(5)1293
[DOI]
268Synergistic Antitumor Activity of Gramicidin/Lipophilic Bismuth Nanoparticles (BisBAL NPs) on Human Cervical Tumor Cells
Claudio Cabral-Romero,Claudia María García-Cuellar,Rene Hernandez-Delgadillo,Yesennia Sánchez-Pérez,Irene Meester,Juan Manuel Solís-Soto,Nayely Pineda-Aguilar,Shankararaman Chellam
Frontiers in Nanotechnology.2021;3(5)1293
[DOI]
269The nephroprotective effects and mechanisms of rehmapicrogenin include ROS inhibition via an oestrogen-like pathway both in vivo and in vitro
Mengmeng Wang,Yingying Ke,Yage Li,Zengfu Shan,Wangyang Mi,Yangang Cao,Weisheng Feng,Xiaoke Zheng
Biomedicine & Pharmacotherapy.2021;138(5)111305
[DOI]
270Protective effects of berberine on various kidney diseases: Emphasis on the promising effects and the underlined molecular mechanisms
Emad H.M. Hassanein,Islam M. Ibrahim,Esraa K. Abd-alhameed,Nesma M. Mohamed,Samir A. Ross
Life Sciences.2022;306(5)120697
[DOI]
271Circ-LTBP1 is involved in doxorubicin-induced intracellular toxicity in cardiomyocytes via miR-107/ADCY1 signal
Chunxia Li,Lihui Zhang,Xingpeng Bu,Jinyu Wang,Li Li,Zhiming Yang
Molecular and Cellular Biochemistry.2022;477(4)1127
[DOI]
272Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years
Natália A. D'Angelo,Mariana A. Noronha,Mayra C.C. Câmara,Isabelle S. Kurnik,Chuying Feng,Victor H.S. Araujo,João H.P.M. Santos,Valker Feitosa,João V.D. Molino,Carlota O. Rangel-Yagui,Marlus Chorilli,Emmanuel A. Ho,André M. Lopes
Biomaterials Advances.2022;133(4)112623
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal